Why the study?
The study was designed to determine the utility of a highly sensitive troponin assay when utilized in the emergency department.
Does high sensitivity troponin testing improve the diagnostic assessment of acute coronary syndrome in early-presenting emergency department patients compared to contemporary testing?
Does high sensitivity troponin testing improve the diagnostic assessment of acute coronary syndrome in early-presenting emergency department patients compared to contemporary testing?
This study protocol outlines a prospective cohort study to evaluate the diagnostic utility of high-sensitivity troponin assays compared to contemporary assays and clinical judgment in early-presenting patients with suspected acute coronary syndrome.
Answers are grounded in this paper and cite their sources.
May aid early rule-out in suspected ACS; leaves open optimal serial testing impact on outcomes.
OBJECTIVE: To determine the utility of a highly sensitive troponin assay when utilized in the emergency department. METHODS: The FAST-TRAC study prospectively enrolled >1,500 emergency department patients with suspected acute coronary syndrome within 6 hours of symptom onset and 2 hours of emergency department presentation. It has several unique features that are not found in the majority of studies evaluating troponin. These include a very early presenting population in whom prospective data collection of risk score parameters and the physician's clinical impression of the probability of acute coronary syndrome before any troponin data were available. Furthermore, two gold standard diagnostic definitions were determined by a pair of cardiologists reviewing two separate data sets; one that included all local troponin testing results and a second that excluded troponin testing so that diagnosis was based solely on clinical grounds. By this method, a statistically valid head-to-head comparison of contemporary and high sensitivity troponin testing is obtainable. Finally, because of a significant delay in sample processing, a unique ability to define the molecular stability of various troponin assays is possible. TRIAL REGISTRATION: ClinicalTrials.gov Identifier NCT00880802.
No takes yet. Share an insight, caveat, or question.
Peacock et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: